SynCon CSPG4

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSynCon CSPG4
Drug Alias Namesynthetic consensus DNA vaccine targeting CSPG4 (Inovio Pharmaceuticals/The Wistar Institute)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionChondroitin sulfate proteoglycan 4 modulators
TargetsChondroitin sulfate proteoglycan 4
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncThe Wistar Institute Of Anatomy And Biology
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A